FindTrial
Sign In

The therapeutic prognosis study cohort of childhood acute lymphoblastic leukemia in South China

The therapeutic prognosis study cohort of childhood acute lymphoblastic leukemia in South China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POC-17013315
Enrollment
Unknown
Registered
2017-11-09
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood acute lymphoblastic leukemia

Interventions

childhood acute lymphoblastic leukemia:CCCG-ALL-2015 multi-center clinical trial

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1) reach the childhood ALL diagnostic criteria: blast percentage >=30% with complete immunophenotype information, karotype, fusion gene, gene mutation; 2) aged 0-18 years old; 3) enter CCCG-ALL-2015 clinical trial.

Exclusion criteria

Exclusion criteria: 1) secondary ALL; 2) without systemic CCCG-ALL-2015 treatment; 3) without informed consent; 4) patient quit the clinical trial.

Design outcomes

Primary

MeasureTime frame
therapeutic prognosis;the completeness of clinical data;construction of tissue bank;loss of follow-up;cure rate;infectious disease due to neutropenia;disease progression;minimal residual disease;quality of life;—

Countries

China

Contacts

Public ContactHUI ZHANG

Guangzhou Women and Children's Medical Center

zhanghuirjh@hotmail.com+86 15821333007

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026